Early changes in plasma glucagon and growth hormone response to oral glucose in experimental hyperthyroidism

Metabolism: Clinical and Experimental

Volumn 45, Issue 8, 1996, Pages 1029-1033

  Tosi, Flavia ^a,b   Moghetti, Paolo ^a   Castello, Roberto ^a   Negri, Carlo ^a   Bonora, Enzo ^a   Muggeo, Michele ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b MAGGIORE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON; GLUCOSE; GROWTH HORMONE; INSULIN; LIOTHYRONINE; THYROID HORMONE;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; GLUCAGON BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GROWTH HORMONE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERTHYROIDISM; INSULIN BLOOD LEVEL; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; THYROTOXICOSIS;

EID: 0029788163     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(96)90275-9     Document Type: Article

References (48)

1. Kreines K, Jett M, Knowles HC: Observations in hyperthyroidism of abnormal glucose tolerance and other traits related to diabetes mellitus. Diabetes 14:740-744, 1965
2. Doar JWH, Stamp TCB, Wynn V, et al: Effects of oral and intravenous glucose loading in thyrotoxicosis. Diabetes 18:633-639, 1969
3. Andreani D, Menzinger G, Fallucca F, et al: Insulin levels in thyrotoxicosis and primary myxoedema: Response to intravenous glucose and glucagon. Diabetologia 6:1-7, 1970
4. Ahren B: Hyperthyroidism and glucose intolerance. Acta Med Scand 220:5-14, 1986
5. Malbon CC, Campbell R: Thyroid hormones regulate hepatic glycogen synthase. Endocrinology 115:681-686, 1984
6. Dimitriadis GD, Leighton B, Vlachonikolis IG, et al: Effects of hyperthyroidism on the sensitivity of glycolysis and glycogen synthesis to insulin in the soleus muscle of the rat. Biochem J 253:87-92, 1988
7. Celsing F, Blomstrand E, Melichna J, et al: Effect of hyperthyroidism on fibre-type composition, fibre area, glycogen content and enzyme activity in human skeletal muscle. Clin Physiol 6:171-181, 1986
8. Bollen M, Stalmans W: The effect of thyroid status on the activation of glycogen synthase in liver cells. Endocrinology 122: 2915-2919, 1988
9. Lomax RB, Robertson WR: The effects of hypo- and hyperthyroidsm on fibre composition and mitochondrial enzyme activities in rat skeletal muscle. J Endocrinol 133:375-380, 1992
10. Kabadi UM, Eisenstein AB: Glucose intolerance in hyperthyroidism: Role of glucagon. J Clin Endocrinol Metab 50:392-396, 1980
11. Wolf E, Eisenstein AB: Portal vein blood insulin and glucagon are increased in experimental hyperthyroidism. Endocrinology 108:2109-2113, 1981
12. Iranmanesh A, Lizarralde G, Johnson ML, et al: Nature of altered growth hormone secretion in hyperthyroidism. J Clin Endocrinol Metab 72:108-115, 1991
13. O'Meara NM, Blackman JD, Sturis J, et al: Alterations in the kinetics of C-peptide and insulin secretion in hyperthyroidism. J Clin Endocrinol Metab 76:79-84, 1993
14. Muller MJ, von Schutz B, Huhnt HJ, et al: Glucoregulatory function of thyroid hormones: Interaction with insulin depends on the prevailing glucose concentration. J Clin Endocrinol Metab 63:62-71, 1986
15. Moghetti P, Castello R, Tosi F, et al: Glucose counterregulatory response to acute hypoglycemia in hyperthyroid human subjects. J Clin Endocrinol Metab 78:169-173, 1994
16. McCulloch AJ, Home PD, Heine R, et al: Insulin sensitivity in hyperthyroidism: Measurement by the glucose clamp technique. Clin Endocrinol (Oxf) 18:327-333, 1983
17. Randin JP, Tappy L, Scazziga B, et al: Insulin sensitivity and exogenous insulin clearance in Graves' disease. Measurement by the glucose clamp technique and continuous indirect calorimetry. Diabetes 35:178-181, 1986
18. Roti E, Braverman LE, Robuschi G, et al: Basal and glucose- and arginine-stimulated serum concentrations of insulin, C-peptide, and glucagon in hyperthyroid patients. Metabolism 35:337-342, 1986
19. Shen D, Davidson MB, Kuo S, et al: Peripheral and hepatic insulin antagonism in hyperthyroidism. J Clin Endocrinol Metab 66:565-569, 1988
20. Bonora E, Manicardi V, Zenere M, et al: Plasma C-peptide response to oral glucose load in hyperthyroidism. J Endocrinol Invest 13:555-558, 1990
21. Ikeda T, Fujiyama K, Hoshino T, et al: Oral and intravenous glucose-induced insulin secretion in hyperthyroid patients. Metabolism 39:633-637, 1990
22. Pestell R, Alford F, Ramos R, et al: Insulin secretion, insulin sensitivity and glucose-mediated glucose disposal in thyrotoxicosis: A minimal model analysis. Clin Endocrinol (Oxf) 33:481-493, 1990
23. Perez G, Ungaro B, Covelli A, et al: Altered glucoregulatory response to physiological infusions of epinephrine and glucagon in hyperthyroidism. J Clin Endocrinol Metab 51:972-977, 1980
24. Lam KSL, Yeung RTT, Ho PWM, et al: Glucose intolerance in thyrotoxicosis: Roles of insulin, glucagon and somatostatin. Acta Endocrinol (Copenh) 114:228-234, 1987
25. Dimitriadis G, Baker B, Marsh H, et al: Effect of thyroid hormone excess on action, secretion, and metabolism of insulin in humans. Am J Physiol 248:E593-E601, 1985
26. Samuels HH, Forman BM, Horowitz ZD, et al: Regulation of gene expression by thyroid hormones. Annu Rev Physiol 51:623-639, 1989
27. Miki N, Ono M, Hizuka N, et al: Thyroid hormone modulation of hypothalamic growth hormone (GH)-releasing factor-pituitary GH axis in the rat. J Clin Invest 90:113-120, 1992
28. Valcavi R, Dieguez C, Zini M, et al: Influence of hyperthyroidism on growth hormone secretion. Clin Endocrinol (Oxf) 38:515-522, 1993
29. Davies RR, Jack D, Turner SJ, et al: The effect of thyroid status on the growth hormone response to growth hormone releasing hormone 1-44. J Endocrinol Invest 12:517-521, 1989
30. Giustina A, Ferrari C, Bodini C, et al: Effects of methimazole treatment on growth hormone (GH) response to GH-releasing hormone in patients with hyperthyroidism. Acta Endocrinol (Copenh) 123:613-618, 1990
31. Giustina A, Schettino M, Bussi AR, et al: Effect of arginine on the GHRH-stimulated GH secretion in patients with hyperthyroidism. Horm Res 38:256-259, 1992
32. Bratusch-Marrain PR, Smith D, DeFronzo RA: The effect of growth hormone on glucose metabolism and insulin secretion in man. J Clin Endocrinol Metab 55:973-982, 1982
33. Moller N, Jorgensen JOL, Alberti KGMM, et al: Short-term effects of growth hormone on fuel oxidation and regional substrate metabolism in normal man. J Clin Endocrinol Metab 70:1179-1186, 1990
34. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1057, 1979
35. Sestoft L, Heding LG: Hypersecretion of proinsulin in thyrotoxicosis. Diabetologia 21:103-107, 1981
36. Beer SF, Parr JH, Temple RC, et al: The effect of thyroid disease on proinsulin and C-peptide levels. Clin Endocrinol (Oxf) 30:379-383, 1989
37. Lenzen S, Joost HG, Hasselblatt A: Thyroid function and insulin secretion from the perfused pancreas in the rat. Endocrinology 99:125-129, 1976
38. Pipher J, Poulsen E: Liver biopsy in thyrotoxicosis. Acta Med Scand 127:439-447, 1947
39. Aranda A, Montoya E, Errera E: Effects of hypo and hyperthyroidism on liver composition, blood glucose, ketone bodies and insulin in the male rat. Biochem J 128:597-604, 1972
40. Kabadi UM: Is hepatic glycogen content a regulator of glucagon secretion? Metabolism 41:113-115, 1992
41. Kabadi UM: Hepatic regulation of pancreatic α-cell function. Metabolism 42:535-543, 1993
42. 3 and elevation in reverse T3 induced by hyperglucagonemia: Changes in thyroid hormone metabolism, not altered release of thyroid hormones. Horm Metab Res 20:513-516, 1988
43. Dillmann WH, Bonner RA, Oppenheimer JH: Glucagon administration decreases hepatic nuclear triiodothyronine binding capacity. Endocrinology 102:1633-1636, 1978
44. Vinik A, Pimstone B, Buchanan-Lee B: Impairment of hyperglycemic induced growth hormone suppression in hyperthyroidism. J Clin Endocrinol 28:1534-1538, 1968
45. Finkelstein JW, Boyar RM, Hellman L: Growth hormone secretion in hyperthyroidism. J Clin Endocrinol Metab 38:634-637, 1974
46. Hansen I, Tsalikian E, Beaufrere B, et al: Insulin resistance in acromegaly: Defects in both hepatic and extrahepatic insulin action. Am J Physiol 250:E269-E273, 1986
47. Press M, Tamborlane MW, Sherwin RS: Importance of raised growth hormone levels in mediating the metabolic derangements of diabetes. N Engl J Med 310:810-815, 1984
48. Salomon F, Cuneo RC, Hesp R, et al: The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med 321:1797-1803, 1989